documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
- comment_end_date
- A FULL UTC INSTANT, not a calendar date, despite the column name: '2026-08-29T03:59:59Z' is 11:59:59 PM EASTERN on 2026-08-28. Federal comment periods close at 11:59:59 PM Eastern, so the UTC calendar date is ONE DAY LATER than the official deadline on every end-of-day close — 444,689 of the 444,690 populated rows (measured 2026-09-06). Convert to America/New_York before presenting a deadline, and compare with julianday(comment_end_date) > julianday('now'): a plain > datetime('now') is a TEXT comparison between two different formats and keeps already-closed dockets matching for up to ~20 hours. The sibling column on open_comments.documents WAS corrected to an Eastern calendar date (queue #498); this one is unchanged and still an instant — the two databases do not agree on grain. (queue #644)
- comment_start_date
- A FULL UTC INSTANT, not a calendar date, despite the column name — same grain as comment_end_date on this table. Convert to America/New_York before presenting it. (queue #644)
17 rows where docket_id = "FDA-2026-N-8249" sorted by posted_date descending
This data as json, CSV (advanced)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-8249-0013 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 11 - Racial differences in detection rate of bladder cancer using blue light cystoscopy | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:44:41Z | 0 | 0 | 09000064b94630a0 | |||
| FDA-2026-N-8249-0017 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 15 - National Cancer Institute Bladder Cancer - Cancer Stat Facts | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:50:10Z | 0 | 0 | 09000064b94630b4 | |||
| FDA-2026-N-8249-0006 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 4 - NDA 22555.S005 Approval | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:36:48Z | 0 | 0 | 09000064b9463099 | |||
| FDA-2026-N-8249-0009 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 7 - P050027 Summary of Safety and Effectiveness (SSED) | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:39:57Z | 0 | 0 | 09000064b946309c | |||
| FDA-2026-N-8249-0010 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 8 - Efficacy and safety of blue light flexible cystoscopy with hexaminolevulinate | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:41:07Z | 0 | 0 | 09000064b946309d | |||
| FDA-2026-N-8249-0011 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 9 - Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:42:19Z | 0 | 0 | 09000064b946309e | |||
| FDA-2026-N-8249-0012 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 10 - Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:43:31Z | 0 | 0 | 09000064b946309f | |||
| FDA-2026-N-8249-0004 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 2 - P050027 Approved Labeling | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:35:02Z | 0 | 0 | 09000064b94573d5 | |||
| FDA-2026-N-8249-0007 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 5 - CDRH-2014-2015-Strategic---Priorities | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:37:47Z | 0 | 0 | 09000064b946309a | |||
| FDA-2026-N-8249-0016 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 14 - Efficacy and safety of hexaminolevulinate fluorescence cystoscopy in the diagnosis of bladder cancer | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:49:22Z | 0 | 0 | 09000064b94630b3 | |||
| FDA-2026-N-8249-0001 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended as an Aid for Detection of Bladder Cancer | Proposed Rule | Request for Comment | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T04:00:00Z | 2026-10-17T03:59:59Z | 2026-10-13T09:00:41Z | 2026-16728 | 1 | 0 | 09000064b9462d5a |
| FDA-2026-N-8249-0003 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 1 - P050027 Approval Order | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:33:43Z | 0 | 0 | 09000064b94573d4 | |||
| FDA-2026-N-8249-0005 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 3 - Oncologic Drugs Advisory Committee Meeting Transcript December 17 2009 | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:35:56Z | 0 | 0 | 09000064b9463098 | |||
| FDA-2026-N-8249-0008 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 6 - First-Cohort-of-Results-of-the-2014-2015-Strategic-Priority | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:38:45Z | 0 | 0 | 09000064b946309b | |||
| FDA-2026-N-8249-0002 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | List of References | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:29:38Z | 0 | 0 | 09000064b94573d3 | |||
| FDA-2026-N-8249-0014 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 12 - Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:45:44Z | 0 | 0 | 09000064b94630a1 | |||
| FDA-2026-N-8249-0015 | FDA | Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended As An Aid For Detection of Bladder Cancer FDA-2026-N-8249 | Reference 13 - Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive | Supporting & Related Material | Background Material | 2026-08-17T04:00:00Z | 2026 | 8 | 2026-08-17T18:48:01Z | 0 | 0 | 09000064b94630b2 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;